Drug Shortage Report for FOQUEST
Report ID | 151791 |
Drug Identification Number | 02470357 |
Brand name | FOQUEST |
Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE (CONTROLLED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-01-07 |
Actual start date | 2022-01-05 |
Estimated end date | 2024-08-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v157 | 2024-04-30 | French | Compare |
v156 | 2024-04-30 | English | Compare |
v155 | 2024-03-06 | French | Compare |
v154 | 2024-03-06 | English | Compare |
v153 | 2023-11-01 | French | Compare |
v152 | 2023-11-01 | English | Compare |
v151 | 2023-10-25 | French | Compare |
v150 | 2023-10-25 | English | Compare |
v149 | 2023-10-17 | French | Compare |
v148 | 2023-10-17 | English | Compare |
v147 | 2023-10-05 | French | Compare |
v146 | 2023-10-05 | English | Compare |
v145 | 2023-10-03 | French | Compare |
v144 | 2023-10-03 | English | Compare |
v143 | 2023-09-22 | French | Compare |
v142 | 2023-09-22 | English | Compare |
v141 | 2023-08-31 | French | Compare |
v140 | 2023-08-31 | English | Compare |
v139 | 2023-08-31 | French | Compare |
v138 | 2023-08-31 | English | Compare |